Association of Structural Forms of 17q21.31 with the Risk of Progressive Supranuclear Palsy and MAPT Sub-haplotypes.

Autor: Wang H; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Penn Neurodegeneration Genomics Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Chang TS; Movement Disorders Programs, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Dombroski BA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Penn Neurodegeneration Genomics Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Cheng PL; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Penn Neurodegeneration Genomics Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Si YQ; Bioinformatics Research Center, North Carolina State University, NC, USA., Tucci A; Bioinformatics Research Center, North Carolina State University, NC, USA., Patil V; Movement Disorders Programs, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Valiente-Banuet L; Movement Disorders Programs, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Farrell K; Department of Pathology, Department of Artificial Intelligence & Human Health, Nash Family, Department of Neuroscience, Ronald M. Loeb Center for Alzheimer's Disease, Friedman Brain, Institute, Neuropathology Brain Bank & Research CoRE, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Mclean C; Victorian Brain Bank, The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia., Molina-Porcel L; Alzheimer's disease and other cognitive disorders unit. Neurology Service, Hospital Clínic, Fundació Recerca Clínic Barcelona (FRCB). Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Neurological Tissue Bank of the Biobanc-Hospital Clínic-IDIBAPS, Barcelona, Spain., Alex R; Movement Disorders Program, Division of Neurology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada., Paul De Deyn P; Laboratory of Neurochemistry and Behavior, Experimental Neurobiology Unit, University of Antwerp, Wilrijk (Antwerp), Belgium.; Department of Neurology, University Medical Center Groningen, NL-9713 AV Groningen, Netherlands., Le Bastard N; Fujirebio Europe NV, Technologiepark 6, 9052 Gent, Belgium., Gearing M; Department of Pathology and Laboratory Medicine and Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA., Donker Kaat L; Netherlands Brain Bank and Erasmus University, Netherlands., Van Swieten JC; Netherlands Brain Bank and Erasmus University, Netherlands., Dopper E; Netherlands Brain Bank and Erasmus University, Netherlands., Ghetti BF; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA., Newell KL; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA., Troakes C; London Neurodegenerative Diseases Brain Bank, King's College London, London, UK., G de Yébenes J; Autonomous University of Madrid, Madrid, Spain., Rábano-Gutierrez A; Fundación CIEN (Centro de Investigación de Enfermedades Neurológicas) - Centro Alzheimer Fundación Reina Sofía, Madrid, Spain., Meller T; Department of Neurology, Philipps-Universität, Marburg, Germany., Oertel WH; Department of Neurology, Philipps-Universität, Marburg, Germany., Respondek G; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Stamelou M; Parkinson's disease and Movement Disorders Department, HYGEIA Hospital, Athens, Greece.; European University of Cyprus, Nicosia, Cyprus., Arzberger T; Department of Psychiatry and Psychotherapy, University Hospital Munich, Ludwig-Maximilians-University Munich, Germany.; Center for Neuropathology and Prion Research, Ludwig-Maximilians-University Munich, Germany., Roeber S; German Brain Bank, Neurobiobank Munich, Germany., Müller U; German Brain Bank, Neurobiobank Munich, Germany., Hopfner F; Department of Neurology, LMU University Hospital, Ludwig-Maximilians-Universität (LMU) München; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; and Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Pastor P; Unit of Neurodegenerative diseases, Department of Neurology, University Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain.; Neurosciences, The Germans Trias i Pujol Research Institute (IGTP) Badalona, Badalona, Spain., Brice A; Sorbonne Université, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, APHP - Hôpital Pitié-Salpêtrière, Paris, France., Durr A; Sorbonne Université, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, APHP - Hôpital Pitié-Salpêtrière, Paris, France., Ber IL; Sorbonne Université, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, APHP - Hôpital Pitié-Salpêtrière, Paris, France., Beach TG; Banner Sun Health Research Institute, Sun City, AZ, USA., Serrano GE; Banner Sun Health Research Institute, Sun City, AZ, USA., Hazrati LN; University McGill, Montreal, Quebec, Canada., Litvan I; Department of Neuroscience, University of California, San Diego, CA, USA., Rademakers R; VIB Center for Molecular Neurology, University of Antwerp, Belgium.; Department of Neuroscience, Mayo Clinic Jacksonville, FL, USA., Ross OA; Department of Neuroscience, Mayo Clinic Jacksonville, FL, USA., Galasko D; Department of Neuroscience, University of California, San Diego, CA, USA., Boxer AL; Memory and Aging Center, University of California, San Francisco, CA, USA., Miller BL; Memory and Aging Center, University of California, San Francisco, CA, USA., Seeley WW; Memory and Aging Center, University of California, San Francisco, CA, USA., Van Deerlin VM; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Lee EB; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, Philadelphia, PA, USA., White CL 3rd; University of Texas Southwestern Medical Center, Dallas, TX, USA., Morris HR; Departmento of Clinical and Movement Neuroscience, University College of London, London, UK., de Silva R; Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, London, UK., Crary JF; Department of Pathology, Department of Artificial Intelligence & Human Health, Nash Family, Department of Neuroscience, Ronald M. Loeb Center for Alzheimer's Disease, Friedman Brain, Institute, Neuropathology Brain Bank & Research CoRE, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Goate AM; Department of Genetics and Genomic Sciences, New York, NY, USA; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Friedman JS; Friedman Bioventure, Inc., Del Mar, CA, USA: Department of Genetics and Genomic Sciences, New York, NY, USA., Leung YY; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Penn Neurodegeneration Genomics Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Coppola G; Movement Disorders Programs, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.; Department of Psychiatry, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA., Naj AC; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Penn Neurodegeneration Genomics Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Wang LS; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Penn Neurodegeneration Genomics Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Dickson DW; Department of Neuroscience, Mayo Clinic Jacksonville, FL, USA., Höglinger GU; Department of Neurology, LMU University Hospital, Ludwig-Maximilians-Universität (LMU) München; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; and Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Tzeng JY; Bioinformatics Research Center, North Carolina State University, NC, USA.; Department of Statistics, North Carolina State University, NC, USA., Geschwind DH; Movement Disorders Programs, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.; Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.; Institute of Precision Health, University of California, Los Angeles, Los Angeles, CA, USA., Schellenberg GD; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Penn Neurodegeneration Genomics Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Lee WP; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Penn Neurodegeneration Genomics Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2024 Feb 28. Date of Electronic Publication: 2024 Feb 28.

Exploring the prevalence and characteristics of adverse drug events among older adults in South Korea using a national health insurance database.

Autor: Eunkyeong Choi, Siin Kim, Hae Sun Suh

Publikováno v: Frontiers in Pharmacology; 12/1/2022, Vol. 13, p01-10, 10p

Clinical and Neuropathological Features of Spastic Ataxia in a Spanish Family with Novel Compound Heterozygous Mutations in STUB1.

Autor: Bettencourt, Conceição, Yébenes, Justo, López-Sendón, José, Shomroni, Orr, Zhang, Xingqian, Qian, Shu-Bing, Bakker, Ingrid, Heetveld, Sasja, Ros, Raquel, Quintáns, Beatriz, Sobrido, María-Jesús, Bevova, Marianna, Jain, Shushant, Bugiani, Marianna, Heutink, Peter, Rizzu, Patrizia

Publikováno v: Cerebellum; Jun2015, Vol. 14 Issue 3, p378-381, 4p

Parkinson's Disease: Diagnosis, Treatment, and Prognosis

Autor: Ito, Ami, Yoshida, Chiyo

Parkinson's disease (PD) is the second most common neurodegenerative disorder and is caused by degeneration and dysfunction of dopaminergic neurons in substantia nigra. The disease usually clinically starts at age 54-60 and the mean duration from dia

Comprehensive Inorganic Chemistry III, Third Edition

Comprehensive Inorganic Chemistry III, a ten-volume reference work, is intended to cover fundamental principles, recent discoveries, and significant applications of elements and their compounds. Authored by renowned experts in the field and edited by